» Articles » PMID: 36656584

Trends and Characteristics of Potentially Preventable Emergency Department Visits Among Patients With Cancer in the US

Overview
Journal JAMA Netw Open
Specialty General Medicine
Date 2023 Jan 19
PMID 36656584
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: An initial step to reducing emergency department (ED) visits among patients with cancer is to identify the characteristics of patients visiting the ED and examine which of those visits could be prevented.

Objective: To explore nationwide trends and characteristics of ED visits and examine factors associated with potentially preventable ED visits and unplanned hospitalizations among patients with cancer in the US.

Design, Setting, And Participants: This cross-sectional study used data on ED visits from the National Hospital Ambulatory Medical Care Survey from January 1, 2012, to December 31, 2019; US Cancer Statistics reports were used to estimate new cancer cases each year. Frequencies and trends among 35 510 014 ED visits by adult patients (aged ≥18 years) with cancer were calculated.

Main Outcomes And Measures: The primary outcome was potentially preventable ED visits, and secondary outcomes were unplanned hospitalizations and the immediacy of the ED visits. Potentially preventable ED visits were identified using the Centers for Medicare & Medicaid Services definition. The Emergency Severity Index, a triage algorithm that ranks patients based on the urgency of their health care condition, was used to measure the immediacy of ED visits (immediate [most urgent], emergent, urgent, less urgent, and nonurgent), with the categories of immediate and emergent classified as high acuity. The Wilcoxon rank sum test was used to calculate trends in ED visits among patients with cancer over time. Multivariable logistic regression analyses were performed to examine the associations of patient, hospital, and temporal factors with potentially preventable ED use and ED use resulting in hospitalization.

Results: Among 854 911 106 ED visits, 35 510 014 (4.2%) were made by patients with cancer (mean [SD] age, 66.2 [16.2] years); of those, 55.2% of visits were among women, 73.2% were among non-Hispanic White individuals, 89.8% were among patients living in a private residence, and 54.3% were among Medicare enrollees. A total of 18 316 373 ED visits (51.6%) were identified as potentially preventable, and 5 770 571 visits (21.3%) were classified as high acuity. From 2012 to 2019, potentially preventable ED visits increased from 1 851 692 to 3 214 276. Pain (36.9%) was the most common reason for potentially preventable ED visits. The number of patients who visited an ED because of pain increased from 1 192 197 in 2012 to 2 405 849 in 2019 (a 101.8% increase). Overall, 28.9% of ED visits resulted in unplanned hospitalizations, which did not change significantly over time (from 32.2% in 2012 to 26.6% in 2019; P = .78 for trend). Factors such as residence in a nursing home (odds ratio, 1.73; 95% CI, 1.25-2.41) were positively associated with having a potentially preventable ED visit, and factors such as the presence of more than 1 comorbidity (odds ratio, 1.82; 95% CI, 1.43-2.32) were positively associated with having an unplanned hospitalization.

Conclusions And Relevance: In this study, 51.6% of ED visits among patients with cancer were identified as potentially preventable, and the absolute number of potentially preventable ED visits increased substantially between 2012 and 2019. These findings highlight the need for cancer care programs to implement evidence-based interventions to better manage cancer treatment complications, such as uncontrolled pain, in outpatient and ambulatory settings.

Citing Articles

Perceived Gaps in Oncologic Emergency Care for Patients with Cancer: A Qualitative Comparison of Emergency Medicine and Oncologist Physician Perspectives.

Wattana M, Davenport M, Bischof J, Lindsay A, Pettit N, Menendez J Cancers (Basel). 2025; 17(5).

PMID: 40075677 PMC: 11899144. DOI: 10.3390/cancers17050828.


Understanding oncologic emergencies and related emergency department visits and hospitalizations: a systematic review.

Yilmaz S, Aryal K, King J, Bischof J, Hong A, Wood N BMC Emerg Med. 2025; 25(1):40.

PMID: 40045233 PMC: 11883922. DOI: 10.1186/s12873-025-01183-2.


Care for patients with cancer and substance use disorders: a qualitative study of oncology team experiences.

Kale S, Rush L, Eramo J, Bitangacha M, Chen S, Check D Support Care Cancer. 2025; 33(2):146.

PMID: 39903305 PMC: 11794404. DOI: 10.1007/s00520-025-09181-7.


The role of ketamine and its enantiomer in managing depression and pain in cancer patients: A narrative review.

Bodnar M, Barber S, Jim H, Huang J J Anesth Transl Med. 2025; 3(4):155-165.

PMID: 39872209 PMC: 11770367. DOI: 10.1016/j.jatmed.2024.10.005.


Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment.

Mao J, Bryl K, Gillespie E, Green A, Hung T, Baser R NPJ Digit Med. 2025; 8(1):29.

PMID: 39809874 PMC: 11733120. DOI: 10.1038/s41746-024-01387-z.


References
1.
Lash R, Hong A, Bell J, Reed S, Pettit N . Recognizing the emergency department's role in oncologic care: a review of the literature on unplanned acute care. Emerg Cancer Care. 2022; 1(1):6. PMC: 9200439. DOI: 10.1186/s44201-022-00007-4. View

2.
Lee P, Le Saux M, Siegel R, Goyal M, Chen C, Ma Y . Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review. Am J Emerg Med. 2019; 37(9):1770-1777. DOI: 10.1016/j.ajem.2019.06.014. View

3.
Parast L, Mathews M, Martino S, Lehrman W, Stark D, Elliott M . Racial/Ethnic Differences in Emergency Department Utilization and Experience. J Gen Intern Med. 2021; 37(1):49-56. PMC: 8021298. DOI: 10.1007/s11606-021-06738-0. View

4.
Zahnd W, McLafferty S . Contextual effects and cancer outcomes in the United States: a systematic review of characteristics in multilevel analyses. Ann Epidemiol. 2017; 27(11):739-748.e3. DOI: 10.1016/j.annepidem.2017.10.002. View

5.
Navari R, Ruddy K, LeBlanc T, Nipp R, Clark-Snow R, Schwartzberg L . Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin. Oncologist. 2020; 26(4):325-331. PMC: 8018299. DOI: 10.1002/onco.13620. View